Recent Finacing
Recent Raise
Inotrem is a Paris-based clinical-stage biotechnology company developing immunotherapies that modulate the TREM-1 pathway to treat acute and chronic inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Inotrem.
